Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 1997

View Archived Issues

Promising efficacy of combination therapy including Viracept for HIV

New thrombin receptor cloned and characterized

Penederm and SmithKline Beecham announce OTC collaboration

IntraBiotics initiates phase I trials of IB-367 for oral mucositis

Ergoset enters clinical trials as adjunct therapy for type II diabetes

GelTex issued U.S. patent for cholesterol-reducing polymers

GelTex reports preliminary phase IIc results for RenaGel

Allelix and Pharm-Eco create partnership

Additional phase I/II trial results for MEDI-493

Xenova reports encouraging data on antithrombotic compound

Pharma Mar describes antitumor compounds from marine sponge

NMDA antagonist revealed by Sumitomo

Pharmacia & Upjohn describes compounds for amyloidosis

Farnesyltransferase inhibitors from Zeneca

Lederle (Japan) reports novel cardioprotective agents

Dual H1/PAF antagonists disclosed by British Biotech

beta-Lactamase inhibitors described by SynPhar

New bradykinin B2 antagonist from Fujisawa

FR-138104: a new D2 antagonist from Fujisawa

Senju describes new calpain inhibitor

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

Retrospective analysis confirms efficacy and safety of Amphotec in aspergillosis

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

Verigen and Tufts to develop transgenic pigs to produce humanized antibodies

Stavudine/didanosine combination safe and effective in AIDS

Amgen obtains additional EPO patent protection

Canadian approval for Depo-Provera

New LTD4 antagonist from Fujisawa

Norastemizole demonstrates high efficacy, safety and rapid onset of action in humans

Cohesion initiates clinical trials of CollaSeal

Pharmacia & Upjohn discontinues roquinimex MS trials

Merck establishes The Merck Genome Research Institute

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...